Elsevier

Differentiation

Volume 104, November–December 2018, Pages 42-49
Differentiation

Review article
Designer macrophages: Pitfalls and opportunities for modelling macrophage phenotypes from pluripotent stem cells

https://doi.org/10.1016/j.diff.2018.10.001Get rights and content

Abstract

Macrophages are phagocytic immune cells resident in every tissue that are not only important for host defence, but are also involved in tissue homeostasis, injury, and disease. Despite increasingly sophisticated methods for in vitro macrophage isolation, expansion and activation over the past three decades, these have largely been restricted to modelling bone-marrow or blood-derived cells. The in vitro derivation of macrophages from human pluripotent stem cells provides new opportunities to study macrophage biology, including the factors that impact human myeloid development and those that induce macrophage activation. While sharing many of the functional characteristics of monocyte-derived macrophages, stem cell-derived macrophages may offer new opportunities to understand the role of development or tissue context in innate immune cell function. Immune responsiveness to pathogenic challenge is known to be impacted by a macrophage's history of prior exposure, as well as ontogeny and tissue context. Therefore, we explore the factors of in vitro derivation likely to influence macrophage phenotype and function.

Introduction

Macrophages (Mф) are specialised phagocytes that are resident in every tissue. Phagocytes are a primitive form of host defence, and one of the most evolutionary conserved components of the immune system (Reviewed by Tauber, 2003). In addition to host defence, mфs have also been implicated in roles as diverse as organogenesis and tissue homeostasis. Innate immune cells, including mфs, have memory-like features often referred to as ‘training’, resulting in an enhanced or hypo-responsiveness to repeated pathogenic challenge. These different functions and roles that mфs play serve to emphasise the importance of developing appropriate in vitro model systems to investigate different aspects of their biology. There has been an increasing number of protocols describing mф derivation processes from stem cells (Fig. 1; Table 1; Supplementary Table 2). These protocols utilise various culture strategies and factors capable of influencing mф maturation, phenotype, function and responsiveness (Fig. 2). This review will first provide an overview of the use of pluripotent stem cells (PSCs) in modelling mф biology and explore aspects of the in vitro environment, including culture conditions, supplemented factors and exposure history, which may impact on the function or polarisation of hPSC-derived mфs.

Section snippets

Opportunity: human pluripotent stem cells for disease modelling in vitro

The ability to derive mфs from human pluripotent stem cells (hPSCs) provides new opportunities to develop models relevant to human genetics. This has resulted in a progressive accumulation of studies that have described human mф functions in both health and disease. For example, human induced pluripotent stem cell (iPSC)-derived mфs have been utilised to investigate Blau Syndrome, a hereditary systemic granulomatosis (Takada et al., 2018). In this study, CRISPR-Cas9 genome editing was used to

Opportunity: macrophage tissue-resident specialisation and ontogeny

The phenotype of hPSC-mфs are largely based on the expression of common blood or myeloid cell surface markers, such as CD14, CD16 and CD68. Assessment of mф function commonly includes assessment of phagocytosis or inflammatory cytokine production (see Supplementary Table 1). However, these general phenotypic assays don’t reflect the diverse functions and complex roles that mфs play in tissue homeostasis, injury or infection. Mфs are found in different tissues with specialised functions that are

Pitfall: the impact of cell culture on macrophage function

As we increasingly become aware of the factors that can contribute to mф heterogeneity and specialisation, it seems obvious to consider the impact of the in vitro environment on derived mфs. For example, exposure of iPSC-derived mфs to feeder cells, serum and embryoid-bodies (EBs) may influence the adoption of a ‘tissue’ mф-like phenotype (or activation-state). EBs, by definition, give rise to cells from the three germ layers (endoderm, ectoderm and mesoderm), so may predispose mфs to resemble

Opportunity: the influence of growth factors and cytokines on macrophage phenotype and function

Since the earliest days of clonal agar expansion of mouse bone marrow progenitors, in vitro models have been used to describe mф differentiation and activation. Typically, macrophage colony stimulating factor (mCSF; CSF-1) and granulocyte macrophage colony stimulating factor (GM-CSF) have been used for clonal expansion of myeloid cells from blood or bone marrow progenitors (Metcalf and Nicola, 1983). The derivation of mфs from hPSCs has evolved over the years, particularly with sequential

Pitfall: the impact of exposure history on cell responsiveness

There is renewed interest in the impact of exposure history on the subsequent responsiveness of a mature mф to pathogenic challenge, although the consequences of early instruction by pathogen, or cytokines, or microenvironment during mф development remains to be fully explored. This is encapsulated in the concept of innate immune ‘training’, a critical mechanism for optimising and resolving inflammatory responses. An aspect of innate immune training has been the ability of mфs to become

Concluding remarks

The importance of mфs in health and disease has led to an increasing demand for in vitro models relevant to human studies. The development of methodologies utilising human stem cells for mф derivation has brought us closer to establishing such models. Upon recapitulation of the essential consequences of ontogeny or tissue niche, we will be closer to developing more specialised tissue-resident mф populations. However, formal evaluation of the impact of the derivation history on the function and

Funding acknowledgements

N.R. is funded by the Centre for Stem Cell Systems and the CSIRO Synthetic Biology Future Science Platform, and C.A.W. is funded by the Australian Research Council (FT150100330) and Stem Cells Australia (SR110001002).

Declarations of interest

None.

Author contributions

N.R.: conception, analysis, figure design and writing

M.R.: conception, figure development and editing

A.L.L: conception and editing

C.A.W: conception and editing

References (79)

  • N. Lachmann

    Large-scale hematopoietic differentiation of human induced pluripotent stem cells provides granulocytes or macrophages for cell replacement therapies

    Stem Cell Rep.

    (2015)
  • Y. Lavin

    Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment

    Cell

    (2014)
  • H. Lindmark

    Gene expression profiling shows that macrophages derived from mouse embryonic stem cells is an improved in vitro model for studies of vascular disease

    Exp. Cell Res.

    (2004)
  • M.J. McAndrew

    Chromatin remodeler recruitment during macrophage differentiation facilitates transcription factor binding to enhancers in mature cells

    J. Biol. Chem.

    (2016)
  • P.J. Murray

    Macrophage activation and polarization: nomenclature and experimental guidelines

    Immunity

    (2014)
  • A.L. Neehus

    Impaired IFNγ-signaling and mycobacterial clearance in IFNγR1-deficient human iPSC-derived macrophages

    Stem Cell Rep.

    (2018)
  • E.S. Ng

    Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation

    Blood

    (2005)
  • T. Okazaki

    Macrophage colony-stimulating factor improves cardiac function after ischemic injury by inducing vascular endothelial growth factor production and survival of cardiomyocytes

    Am. J. Pathol.

    (2007)
  • D. Schmidt et al.

    Fetal bovine serum xenoproteins modulate human monocyte adhesion and protein release on biomaterials in vitro

    Acta Biomater.

    (2011)
  • L. Vergani et al.

    Modifications of chromatin structure and gene expression following induced alterations of cellular shape

    Int. J. Biochem. Cell Biol.

    (2004)
  • K.C. Weisel

    Stromal cell lines from the aorta-gonado-mesonephros region are potent supporters of murine and human hematopoiesis

    Exp. Hematol.

    (2006)
  • Y. Xiao

    Identification of the common origins of osteoclasts, macrophages, and dendritic cells in human hematopoiesis

    Stem Cell Rep.

    (2015)
  • J. Xue

    Transcriptome-based network analysis reveals a spectrum model of human macrophage activation

    Immunity

    (2014)
  • S. Yona

    Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis

    Immunity

    (2013)
  • Y. Zhan

    Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice

    Blood

    (1998)
  • E.M. Abud

    iPSC-derived human microglia-like cells to study neurological diseases

    Neuron

    (2017)
  • K. Alasoo

    Transcriptional profiling of macrophages derived from monocytes and iPS cells identifies a conserved response to LPS and novel alternative transcription

    Sci. Rep.

    (2015)
  • J.S. Anderson

    Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy

    Retrovirology

    (2006)
  • B.M. Baker et al.

    Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues

    J. Cell Sci.

    (2012)
  • S.K. Butcher

    Toll-like receptors drive specific patterns of tolerance and training on restimulation of macrophages

    Front. Immunol.

    (2018)
  • R.J. Carmody

    Negative regulation of toll-like receptor signaling by NF-κB p50 ubiquitination blockade

    Science

    (2007)
  • K.-D. Choi

    Hematopoietic and endothelial differentiation of human induced pluripotent stem cells

    Stem Cells

    (2009)
  • K.-D. Choi et al.

    Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells

    Nat. Protoc.

    (2011)
  • P. Chomarat

    IL-6 switches the differentiation of monocytes from dendritic cells to macrophages

    Nat. Immunol.

    (2000)
  • P.E. Collins et al.

    The regulation of endotoxin tolerance and its impact on macrophage activation

    Crit. Rev. TM Immunol.

    (2015)
  • A.J. Fleetwood

    Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation

    J. Immunol.

    (2007)
  • S.L. Foster et al.

    Gene-specific control of inflammation by TLR-induced chromatin modifications

    Nature

    (2007)
  • P. Garcia-Valtanen

    Evaluation of trained immunity by β-1, 3 (d)-glucan on murine monocytes in vitro and duration of response in vivo

    Immunol. Cell Biol.

    (2017)
  • E.L. Gautiar

    Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages

    Nat. Immunol.

    (2012)
  • Cited by (9)

    • A fully defined matrix to support a pluripotent stem cell derived multi-cell-liver steatohepatitis and fibrosis model

      2021, Biomaterials
      Citation Excerpt :

      Although the latter best mimic human liver, the scarcity of human liver cells and high inter-donor variation [7,8] represent important drawbacks. With the advent of pluripotent stem cells (PSCs) [9], it is now possible to create PSC-derived hepatocyte- [10], HSC- [11], EC- [12] and Mϕ-like cells [13]. As PSCs are an inexhaustible cell population, this approach overcomes the issues related to low cell numbers and inter-donor variability of primary samples.

    • Differentiation of human induced pluripotent stem cells to authentic macrophages using a defined, serum-free, open-source medium

      2021, Stem Cell Reports
      Citation Excerpt :

      In mammals, resident macrophages support tissue homeostasis through a wide range of specialized trophic, remodeling, and defense functions, whose importance is illustrated by their failure in malignant, degenerative, and infectious diseases (Gordon et al., 2014; Steinman and Moberg, 1994). Numerous methods for the differentiation of macrophages from stem cells have been developed over the years, building upon advances in our understanding of the requirements for hematopoiesis (Rajab et al., 2018; Rowe et al., 2016). These can be broadly categorized into three types: monolayer cultures, co-cultures with xeno cells, and via embryoid body (EB) intermediates.

    • An integrated analysis of human myeloid cells identifies gaps in in vitro models of in vivo biology

      2021, Stem Cell Reports
      Citation Excerpt :

      It might be argued that human macrophages suffer from an identity crisis, relying on equivalency to laboratory models of human macrophage biology such as ex vivo culture of monocyte-derived macrophages, which may not be appropriate as a benchmark for specialized tissue functions. Pluripotent stem cells provide new opportunities to model tissue residency, disease phenotypes and activation status of human macrophages (reviewed by Lee et al., 2018; Rajab et al., 2018). However, the anatomic context or ontogeny of PSC-derived cells is still not well understood, nor their capacity to model specialized myeloid behaviors within a tissue niche.

    • Incorporating Tumor-Associated Macrophages into Engineered Models of Glioma

      2020, iScience
      Citation Excerpt :

      To specifically model GBM tumors, cerebral organoids can be genetically manipulated to develop oncogenic properties (Bian et al., 2018; Ogawa et al., 2018), or co-cultured with tumor spheroids to study tumor cell invasion (da Silva et al., 2018; Linkous et al., 2019). To date, iPSC-derived cerebral and glioma organoids containing microglia and macrophages have not yet been established, although the generation of both cell types from iPSCs has been described (Rajab et al., 2018). We anticipate that multicellular glioma organoid technology will provide exciting opportunities to study TAMs during multiple stages of cancer development.

    View all citing articles on Scopus
    View full text